-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JyW5zgr3q8HphFlQ4xTo3NNaraCVxaqopfFgTWMGjkfAJbcE6h+7gwCzS16EBCnV lPiEkCyCQGDdDxPzR1CJpQ== 0000940180-98-000160.txt : 19980218 0000940180-98-000160.hdr.sgml : 19980218 ACCESSION NUMBER: 0000940180-98-000160 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980217 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NEXMED INC CENTRAL INDEX KEY: 0001017491 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870449967 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-53409 FILM NUMBER: 98541198 BUSINESS ADDRESS: STREET 1: 350 CORPORATE BLVD CITY: ROBBINSVILLE STATE: NJ ZIP: 08691 BUSINESS PHONE: 6092080688 MAIL ADDRESS: STREET 1: 350 CORPORATE BLVD CITY: ROBBINSVILLE STATE: NJ ZIP: 08691 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CDC VENTURE INVESTMENT ASIA LTD CENTRAL INDEX KEY: 0001055375 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 350 CORPORATE BLVD STREET 2: C/O NEXMED INC CITY: ROBBINSVILLE STATE: NJ ZIP: 08691 MAIL ADDRESS: STREET 1: 350 CORPORATE BLVD STREET 2: C/O NEXMED INC CITY: ROBBINSVILLE STATE: NJ ZIP: 08691 SC 13G 1 SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ______________ SCHEDULE 13G (RULE 13D-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b) AND (c) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ____)/1/ NexMed, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $0.001 par value per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 652903 10 5 ----------- (CUSIP Number) - ----------------- /1/ The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 652903 10 5 13G Page 2 of 6 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) CDC Venture Investment (Asia) Limited - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF 500,000 SHARES 6 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY 7 SOLE DISPOSITIVE POWER EACH 500,000 REPORTING 8 SHARED DISPOSITIVE POWER PERSON WITH 0 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 500,000 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* (b) [_] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 652903 10 5 13G Page 3 of 6 Pages ITEM 1(a). NAME OF ISSUER: NexMed, Inc. ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 350 Corporate Boulevard Robbinsville, New Jersey 08691 ITEM 2(a). NAME OF PERSON FILING: CDC Venture Investment (Asia) Limited ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 11th Floor, CDC Tower 125 Nanking East Road, Sec. 5 Taipei 10572, Taiwan ITEM 2(c). CITIZENSHIP: British Virgin Islands ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, $0.001 par value per share ITEM 2(e). CUSIP NUMBER: 652903 10 5 CUSIP No. 652903 10 5 13G Page 4 of 6 Pages ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b) CHECK WHETHER THE PERSON FILLING IS A: Not applicable. ITEM 4. OWNERSHIP. (a) Amount beneficially owned: 500,000 (b) Percent of class: 8.1% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 500,000 ------- (ii) Shared power to vote or to direct the vote 0 ------- (iii) Sole power to dispose or to direct the disposition of 500,000 ------- (iv) Shared power to dispose or to direct the disposition of 0 -------
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities check the following. [_] CUSIP No. 652903 10 5 13G Page 5 of 6 Pages ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable. ITEM 10. CERTIFICATION. Not applicable. CUSIP No. 652903 10 5 13G Page 6 of 6 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 13, 1998 --------------------------------- Date CDC VENTURE INVESTMENT (ASIA) LIMITED BY: /s/ Brian C. Keng --------------------------------- Brian C. Keng, Director -----END PRIVACY-ENHANCED MESSAGE-----